Differential efficacy of nicotine replacement among overweight and obese women smokers.
Introduction Rates of obesity are higher among more dependent smokers and 37-65% of smokers seeking cessation treatment are overweight or obese. Overweight or obese smokers may possess metabolic and neurobiological features that contribute to difficulty achieving cessation using front-line nicotine...
Κύριοι συγγραφείς: | Strong, DR, David, S, Johnstone, E, Aveyard, P, Murphy, M, Munafò, M |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2014
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
ανά: Marteau, T, κ.ά.
Έκδοση: (2012) -
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
ανά: Munafo, M, κ.ά.
Έκδοση: (2009) -
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
ανά: Munafò, MR, κ.ά.
Έκδοση: (2009) -
Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
ανά: Theresa M Marteau, κ.ά.
Έκδοση: (2012-01-01) -
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
ανά: Uhl, G, κ.ά.
Έκδοση: (2010)